Resources
Home / Resources
Providing the best advocacy resources for biosimilars.
Whether you are a patient, caregiver, medical professional, payer, policymaker, or you just want to know more about biosimilars, our resources will teach you everything you need to know. Browse through our list below to learn more, and feel free to contact us.
The Biosimilars
Patient Resource Center
The Biosimilars Patient Resource Center is a convenient site for answers to your pressing questions about biosimilar medicines.
Whether you are a current or potential biosimilar or biologics patient, a caregiver, a medical professional, a policymaker, or if you just want to know more about biosimilars, the Biosimilars Patient Resource Center has information you can use.
The Biosimilars Handbook
The Biosimilars Handbook is the premier resource for biosimilar education.
Choose from one of four different tracks below – or check out our additional suggested resources – to learn how biosimilars and interchangeable biologic products can decrease costs and increase access to lifesaving medicines. we’re advocating for right now, and make your voice heard to get these policies across the finish line.
For Patients and Caregivers
FDA – Biosimilars: What Patients Need to Know
Patients Increasingly Rely on Oncology Biosimilar Medicines
Biosimilar Medicines Equal More Accessible Care for America’s Patients
For Medical Professionals
AAM Annual Savings Report – Biosimilars and Bending the Cost Curve
Increasing Provider Reimbursement for Biosimilars Will Lead to Greater Adoption
FDA Biosimilars Approvals
For Payers
AAM Annual Savings Report – Biosimilars and Bending the Cost Curve
Increasing Provider Reimbursement for Biosimilars Will Lead to Greater Adoption
New Analyses Point to Opportunities to Increase Savings from Biosimilar Adoption
For Policymakers
The U.S. Generic & Biosimilar Medicines Savings Report
Increase Patient Access to Lower-Cost Biosimilar Medicines
Top Biosimilar Resources
![biosimilar 101 Biosimilar Development](https://biosimilarscouncil.org/wp-content/uploads/2022/04/Grupo-3539.png)
Biosimilars 101
Biosimilars are a safe, effective, and more affordable option for many patients who rely on biologic treatments.
![Biosimilar patients Doctor helping patient](https://biosimilarscouncil.org/wp-content/uploads/2022/04/Grupo-3520.png)
FDA Biosimilars Approvals
Find an up-to-date list of FDA-approved biosimilars and launches.
2023 U.S. Generic and Biosimilar Medicines Savings Report
This annual report is produced by the Institute for Human Data Science (IQVIA), the standard-bearer for measuring data, pharmaceutical use and spending in the United States.
![Grupo 3535](https://biosimilarscouncil.org/wp-content/uploads/2022/04/Grupo-3535.png)
Interchangeability 101 – Biosimilars and Interchangeable Biologics
This white board video from the Biosimilars Council walks through the basics of interchangeability and why biosimilars and interchangeable biologics are more than acceptable replacements for brand biologics.
Other Resources
Filter by Keyword
More results...
- All
- Backgrounder
- Biosimilars Bulletin
- Blog
- Council Resource
- Event
- Handbook
- Infographic
- Issue Brief
- Member Spotlight
- Partner Resource
- Policy Recommendation
- Press Release
- Report
- Video
- Whitepapers
![2024-FoB-SM-2](https://biosimilarscouncil.org/wp-content/uploads/2024/04/2024-FoB-SM-2-1024x576.jpg)
Last week’s Festival of Biologics in San Diego came during a critical time for our industry when unfolding challenges and… Read more »
![Young woman injecting insulin in hers arm Young woman injecting insulin in hers arm at home](https://biosimilarscouncil.org/wp-content/uploads/2024/03/iStock-1136063320-1024x436.jpg)
As policymakers continue to discuss ways to lower the cost of medicines for patients, the role of pharmacy benefit managers… Read more »
![Monoclonal antibodies (Adalimumab) Monoclonal antibodies (Adalimumab)](https://biosimilarscouncil.org/wp-content/uploads/2024/01/monoclonal-antibodies-adalimumab-1024x562.jpg)
Last year’s launch of the first biosimilar of Humira (adalimumab) signified a major opportunity to increase patient access to, and… Read more »
![March Bulletin](https://biosimilarscouncil.org/wp-content/uploads/2023/05/unnamed-5-1024x317.png)
As we approach the end of the year, we wanted to share a few highlights. This was an active year… Read more »
![2023 Savings Report Blog Header](https://biosimilarscouncil.org/wp-content/uploads/2023/12/2023-savings-report-BC-blog-header-1024x539.jpg)
![interchangeability-blog-header-2](https://biosimilarscouncil.org/wp-content/uploads/2023/11/interchangeability-blog-header-2-1024x512.jpg)
![iStock-1333759837-web vial bottles](https://biosimilarscouncil.org/wp-content/uploads/2023/11/iStock-1333759837-web-1024x684.jpg)
Since 2015, the U.S. Food and Drug Administration (FDA) has approved 42 total biosimilars, delivering safe and effective care for… Read more »
![March Bulletin](https://biosimilarscouncil.org/wp-content/uploads/2023/05/unnamed-5-1024x317.png)
![March Bulletin](https://biosimilarscouncil.org/wp-content/uploads/2023/05/unnamed-5-1024x317.png)
Biosimilars allies – as everyone returns from the summer, September marks the beginning of a busy fall for the Biosimilars… Read more »
![Semglee-Analysis-blog-header-1230x430](https://biosimilarscouncil.org/wp-content/uploads/2023/07/Semglee-Analysis-blog-header-1230x430-1-1024x358.jpg)
![March Bulletin](https://biosimilarscouncil.org/wp-content/uploads/2023/05/unnamed-5-1024x317.png)
![Semglee-Analysis-blog-header-1230x430](https://biosimilarscouncil.org/wp-content/uploads/2023/07/Semglee-Analysis-blog-header-1230x430-1-1024x358.jpg)
![iqvia-report-v2](https://biosimilarscouncil.org/wp-content/uploads/2023/06/iqvia-report-v2-1024x354.png)
![Humira_Amjevita](https://biosimilarscouncil.org/wp-content/uploads/2023/05/Screen-Shot-2023-05-15-at-3.26.50-PM-1024x350.png)
![March Bulletin](https://biosimilarscouncil.org/wp-content/uploads/2023/05/unnamed-5-1024x317.png)
![March Bulletin](https://biosimilarscouncil.org/wp-content/uploads/2023/05/unnamed-5-1024x317.png)
![022023-Biosimilars-Bulletin-blog-header](https://biosimilarscouncil.org/wp-content/uploads/2023/03/022023-Biosimilars-Bulletin-blog-header-1024x663.jpg)
![Access 2023](https://biosimilarscouncil.org/wp-content/uploads/2023/03/IJC00981-1024x683.jpg)
![Screen Shot 2023-02-24 at 4.11.17 PM](https://biosimilarscouncil.org/wp-content/uploads/2023/02/Screen-Shot-2023-02-24-at-4.11.17-PM-e1677273114162-1024x374.png)
![012023-Biosimilars-Bulletin-blog-header-mark-cuban](https://biosimilarscouncil.org/wp-content/uploads/2023/03/012023-Biosimilars-Bulletin-blog-header-mark-cuban-1024x663.jpg)
![Biosimilars-Bulletin-blog-header-Dec-2022](https://biosimilarscouncil.org/wp-content/uploads/2023/01/Biosimilars-Bulletin-blog-header-Dec-2022-1024x662.jpg)
![Biosimilars-Bulletin-blog-header-Nov-2022](https://biosimilarscouncil.org/wp-content/uploads/2023/01/Biosimilars-Bulletin-blog-header-Nov-2022-1024x663.jpg)
![Attendees People at GRx+Biosims](https://biosimilarscouncil.org/wp-content/uploads/2022/11/0A7A7784-e1669166506515-1024x366.jpg)
![Biosimilars-Bulletin-blog-header-Oct-2022](https://biosimilarscouncil.org/wp-content/uploads/2023/01/Biosimilars-Bulletin-blog-header-Oct-2022-1024x663.jpg)
![Pink Ribbon Breast Cancer Girls Feminine Copy Space Banner Conce](https://biosimilarscouncil.org/wp-content/uploads/2022/10/Cancer-Awareness-e1666361984635-1024x548.jpg)
![Young male pharmacist giving prescription medications to senior female customer in a pharmacy](https://biosimilarscouncil.org/wp-content/uploads/2022/10/Pharmacist-and-patient-e1665582542880-1024x476.jpg)
![Biosimilars-Bulletin-blog-header-Sep-2022](https://biosimilarscouncil.org/wp-content/uploads/2022/10/Biosimilars-Bulletin-blog-header-Sep-2022-1024x662.jpg)
![I'm glad to see you doing well!](https://biosimilarscouncil.org/wp-content/uploads/2022/10/Patient-biosimilar-access-e1665064382859-1024x343.jpg)
![2022-savings-report-BC-blog-header](https://biosimilarscouncil.org/wp-content/uploads/2022/09/2022-savings-report-BC-blog-header-1024x662.jpg)
![Biosimilars-Bulletin-blog-header-Aug-2022](https://biosimilarscouncil.org/wp-content/uploads/2022/09/Biosimilars-Bulletin-blog-header-Aug-2022-1024x662.jpg)
![Biosimilars-Bulletin-blog-header-July-2022](https://biosimilarscouncil.org/wp-content/uploads/2022/08/Biosimilars-Bulletin-blog-header-July-2022-1-1024x663.jpg)
![Smiling medical team standing together outside a hospital](https://biosimilarscouncil.org/wp-content/uploads/2022/08/Doctors-together-e1660571354189-1024x525.jpg)
![United States Capitol Building: Calm Before The Storm Congress considers BBB Drug pricing negotiation](https://biosimilarscouncil.org/wp-content/uploads/2022/07/iStock-620402950-1024x683.jpg)
![Biosimilars-Bulletin-blog-Header-June-2022 Biosimilar Bulletin June 2022, doctor advising patient.](https://biosimilarscouncil.org/wp-content/uploads/2022/07/Biosimilars-Bulletin-blog-Header-June-2022-e1657133873812-1024x563.jpg)
![Screen Shot 2022-06-27 at 4.36.11 PM Biosimilars help patients have more accessible care infographic](https://biosimilarscouncil.org/wp-content/uploads/2022/06/Screen-Shot-2022-06-27-at-4.36.11-PM-1024x387.png)
![Biosimilars-Bulletin-blog-Header-May-2022 Biosimilars patient resource center, bulletin](https://biosimilarscouncil.org/wp-content/uploads/2022/06/Biosimilars-Bulletin-blog-Header-May-2022-1024x663.jpg)
![Screen Shot 2022-06-02 at 9.59.00 AM](https://biosimilarscouncil.org/wp-content/uploads/2022/05/Screen-Shot-2022-06-02-at-9.59.00-AM-e1654178523359-1024x353.png)
![The Federal Trade Commission The Federal Trade Commission](https://biosimilarscouncil.org/wp-content/uploads/2022/05/iStock-1384455169-e1653330552621-1024x647.jpg)
![Biosimilars Patient Resource Center Biosimilars Patient Resource Center](https://biosimilarscouncil.org/wp-content/uploads/2022/05/homepage-laptop-mockup-1-e1652988267295-1024x517.jpg)
![Biosimilars-Bulletin-blog-Header-Apr-2022 Doctor helping biosimilar patient](https://biosimilarscouncil.org/wp-content/uploads/2022/05/Biosimilars-Bulletin-blog-Header-Apr-2022-e1652722363376-1024x576.jpg)
![Biosimilars-Bulletin-blog-Header-Mar-2022](https://biosimilarscouncil.org/wp-content/uploads/2022/04/Biosimilars-Bulletin-blog-Header-Mar-2022-1024x663.jpg)
![BC-HHS-Biosimilars-MedicarePartD-Beneficiaries-header](https://biosimilarscouncil.org/wp-content/uploads/2022/04/BC-HHS-Biosimilars-MedicarePartD-Beneficiaries-header-e1648834380247-1024x399.png)
![Biosimilar Patient Greg Biosimilars helping patients](https://biosimilarscouncil.org/wp-content/uploads/2022/03/Greg_web_header-e1647963533129-1024x476.jpg)
![Biosimilar Patient Eileen Biosimilars Helping patient](https://biosimilarscouncil.org/wp-content/uploads/2022/03/IMG-Eileen-02-web-e1647356842659-1024x478.jpg)
![Biosimilars and gavel Biosimilar law policy](https://biosimilarscouncil.org/wp-content/uploads/2022/03/iStock-1307923414-e1647025359624-1024x512.jpg)
![Biosimilars-Bulletin-Header-Feb-2022-1200w](https://biosimilarscouncil.org/wp-content/uploads/2022/03/Biosimilars-Bulletin-Header-Feb-2022-1200w-e1646756972116-1024x445.png)
![Access Slider](https://biosimilarscouncil.org/wp-content/uploads/2021/11/Access-Slider-e1645732249697-1024x363.jpg)
![Looking ahead to 2022 Biosimilars in 2022](https://biosimilarscouncil.org/wp-content/uploads/2022/02/2022-e1643983517201-1024x481.jpg)
![rheumatoid arthritis Rheumatoid Arthritis awareness](https://biosimilarscouncil.org/wp-content/uploads/2022/02/Rheumatoid-Arthritis-1024x681.jpg)
![Biosimilars-Bulletin-Header-2021-year-in-review-1200w](https://biosimilarscouncil.org/wp-content/uploads/2022/01/Biosimilars-Bulletin-Header-2021-year-in-review-1200w-e1641233467242-1024x402.png)
![Hospital Ward: Professional Black Head Nurse Wearing Face Mask Does Checkup of Patient's Vitals, Checking Heart Rate Computer, Intravenous or Iv Fluids Drip Bag. Caring Nurse Monitors Person Recovery](https://biosimilarscouncil.org/wp-content/uploads/2021/12/blog-e1640038399287-1024x351.jpg)
![Biosimilars-Bulletin-Header-Nov-2021-1200w](https://biosimilarscouncil.org/wp-content/uploads/2021/12/Biosimilars-Bulletin-Header-Nov-2021-1200w-e1638819089616-1024x517.jpg)
![biosimilar](https://biosimilarscouncil.org/wp-content/uploads/2021/12/biosimilar-1024x404.jpg)
![grxbiosims-2021-biosimilar-council-recap-header-2](https://biosimilarscouncil.org/wp-content/uploads/2021/11/grxbiosims-2021-biosimilar-council-recap-header-2-1024x683.jpg)
![Biosimilars-Bulletin-Header-Oct-2021-1200w](https://biosimilarscouncil.org/wp-content/uploads/2021/11/Biosimilars-Bulletin-Header-Oct-2021-1200w-e1635958624693-1024x346.png)
![Multi-ethnic women with breast cancer awareness ribbons](https://biosimilarscouncil.org/wp-content/uploads/2021/10/iStock-1170994066-1024x689.jpg)
![Bending curve](https://biosimilarscouncil.org/wp-content/uploads/2021/10/Bending-curve-1024x586.png)
![Savings Report Banner](https://biosimilarscouncil.org/wp-content/uploads/2021/10/Savings-Report-Banner-1024x576.png)
![Biosimilars-Bulletin-Header-Sep-2021-web_2 Biosimilar information](https://biosimilarscouncil.org/wp-content/uploads/2021/10/Biosimilars-Bulletin-Header-Sep-2021-web_2-e1633619709662-1024x502.jpg)
![FDA-approved biosimilars FDA-approved biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2020/04/shutterstock_1349493995-1024x684.jpg)
![BC Bulletin_August Biosimilar information](https://biosimilarscouncil.org/wp-content/uploads/2021/09/BC-Bulletin_August-e1630698509122-1024x371.jpg)
![biosimilars-1024x683](https://biosimilarscouncil.org/wp-content/uploads/2021/08/biosimilars-1024x683-1.jpg)
![patient access one pager (4) patient access to biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2020/03/patient-access-one-pager-4-1024x683.png)
![Resource (Extra Large) (10)](https://biosimilarscouncil.org/wp-content/uploads/2019/10/Resource-Extra-Large-10.jpg)
![The Biosimilars Council - Doctors with hands in the middle The Biosimilars Council - Doctors with hands in the middle](https://biosimilarscouncil.org/wp-content/uploads/2017/10/shutterstock_609423461.jpg)
![shutterstock_1040956534](https://biosimilarscouncil.org/wp-content/uploads/2019/05/shutterstock_1040956534-1024x683.jpg)
Biosimilar competition has the potential to provide greater access to important treatments for America’s patients and cost savings for the… Read more »
![shutterstock_606777308](https://biosimilarscouncil.org/wp-content/uploads/2019/05/shutterstock_606777308.jpg)
![Biosimilars-Council-Akaimi-story Akaimi, 44, San Antonio, TX | Leukemia](https://biosimilarscouncil.org/wp-content/uploads/2021/05/Biosimilars-Council-Akaimi-story-1024x512.jpg)
![biosimilars-in-the-us-blog-header](https://biosimilarscouncil.org/wp-content/uploads/2021/05/biosimilars-in-the-us-blog-header-3-1024x682.png)
![Senior Adult at Medical Appointment Doctor meets with diabetic senior woman at medical appointment](https://biosimilarscouncil.org/wp-content/uploads/2021/04/iStock-1224299026-1024x717.jpg)
![access-2021](https://biosimilarscouncil.org/wp-content/uploads/2021/04/access-2021-TW-1024x576.png)
![reimbursements and uptake to impact header](https://biosimilarscouncil.org/wp-content/uploads/2021/03/reimbursements-and-uptake-to-impact-header-1024x683.png)
![securing sustainable markets](https://biosimilarscouncil.org/wp-content/uploads/2021/02/securing-sustainable-markets-1024x683.png)
![biosimilars bulletin_jan2021 biosimilars news january 2021](https://biosimilarscouncil.org/wp-content/uploads/2021/03/biosimilars-bulletin_jan2021-1024x683.png)
![world cancer day world cancer day](https://biosimilarscouncil.org/wp-content/uploads/2021/02/world-cancer-day-1024x683.png)
![biosimilars bulletin_dec2020 biosimilars news december 2020](https://biosimilarscouncil.org/wp-content/uploads/2021/03/biosimilars-bulletin_dec2020-1024x683.png)
![biosimilars-facts biosimilars facts](https://biosimilarscouncil.org/wp-content/uploads/2020/12/biosimilars-facts-1024x683.png)
![helen_relies_on_biosimilars_header3 helen relies on biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2020/12/helen_relies_on_biosimilars_header3-1024x683.png)
![biosimilars bulletin_nov2020 biosimilars news november 2020](https://biosimilarscouncil.org/wp-content/uploads/2021/03/biosimilars-bulletin_nov2020-1024x683.png)
![grx+biosims 2020 grx+biosims 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/12/grxbiosims-2020-1-1024x683.png)
![doctor high five global biosimilars week](https://biosimilarscouncil.org/wp-content/uploads/2020/11/doctor-high-five-1024x683.png)
![Patent Abuse United States Courthouse Close Up view](https://biosimilarscouncil.org/wp-content/uploads/2019/05/Patent-Abuse.png)
![biosimilars bulletin_oct2020 biosimilars news october 2020](https://biosimilarscouncil.org/wp-content/uploads/2021/03/biosimilars-bulletin_oct2020-1024x683.png)
![b10similars blog ten years of biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2020/10/b10similars-blog-1024x683.png)
![biosimilars help cancer patients biosimilars help cancer patients](https://biosimilarscouncil.org/wp-content/uploads/2020/10/biosimilars-help-cancer-patients-1-1024x683.png)
![biosimilars bulletin_sept2020 biosimilars bulletin september 2020](https://biosimilarscouncil.org/wp-content/uploads/2021/03/biosimilars-bulletin_sept2020-1024x683.png)
![patient biosimilar stories jeni (1)](https://biosimilarscouncil.org/wp-content/uploads/2020/10/patient-biosimilar-stories-jeni-1-1024x683.png)
![shutterstock_1169616739 increasing access to biosimilars act](https://biosimilarscouncil.org/wp-content/uploads/2019/10/shutterstock_1169616739.jpg)
![Biosimilars News May 2020 Biosimilars News May 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/09/Biosimilars-News-May-2020-1024x683.png)
![pipettes twitter chat](https://biosimilarscouncil.org/wp-content/uploads/2020/03/pipettes-1024x683.png)
![Bulletin-Jan2020 biosimilars news january 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/04/Bulletin-Jan2020-1024x683.png)
![FDA-approved biosimilars FDA-approved biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2020/04/shutterstock_1349493995-1024x684.jpg)
![Biosimilars Bulletin August 2020 Biosimilars News August 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/09/Biosimilars-Bulletin-August-2020-1024x683.png)
![Biosimilars Bulletin July 2020 Biosimilars News July 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/09/Biosimilars-Bulletin-July-2020-1024x683.png)
![alternative to biologic medicines alternative to biologic medicines](https://biosimilarscouncil.org/wp-content/uploads/2020/07/alternative-to-biologic-medicines-1-1024x683.png)
![biosimilars benefit everyone biosimilars benefit everyone](https://biosimilarscouncil.org/wp-content/uploads/2020/07/biosimilars-benefit-everyone-1024x683.png)
![biosimilars in the pharmacy biosimilars in the pharmacy](https://biosimilarscouncil.org/wp-content/uploads/2020/07/biosimilars-in-the-pharmacy-2-1024x683.png)
![Biosimilars Bulletin June 2020 Biosimilars news June 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/09/Biosimilars-Bulletin-June-2020-1024x683.png)
![Biosimilars News May 2020 Biosimilars News May 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/09/Biosimilars-News-May-2020-1024x683.png)
![EU Biosimilars Market europe's biosimilars market](https://biosimilarscouncil.org/wp-content/uploads/2020/06/EU-Biosimilars-Market-1024x683.png)
![Bulletin-Apr2020 biosimilars news april 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/04/Bulletin-Apr2020-1024x683.png)
![Bulletin-Mar2020 Bulletin March](https://biosimilarscouncil.org/wp-content/uploads/2020/04/Bulletin-Mar2020-1024x683.png)
![ERIC Resources (2) Resources](https://biosimilarscouncil.org/wp-content/uploads/2020/04/ERIC-Resources-2-1024x683.png)
![pipettes twitter chat](https://biosimilarscouncil.org/wp-content/uploads/2020/03/pipettes-1024x683.png)
![PRI Study Image](https://biosimilarscouncil.org/wp-content/uploads/2020/03/purple-vials-1-1024x683.png)
![Biosimilars Council - Speaker](https://biosimilarscouncil.org/wp-content/uploads/2018/09/shutterstock_720909712.jpg)
![Bulletin-Jan2020 biosimilars news january 2020](https://biosimilarscouncil.org/wp-content/uploads/2020/04/Bulletin-Jan2020-1024x683.png)
![shutterstock_1169616739 biosimilars year in review](https://biosimilarscouncil.org/wp-content/uploads/2020/01/shutterstock_1169616739.jpg)
![Biosimilars in the US biosimilars in the united states](https://biosimilarscouncil.org/wp-content/uploads/2019/11/Biosimilars-in-the-US-1024x683.png)
![GRx+Biosims 2019 (1)](https://biosimilarscouncil.org/wp-content/uploads/2019/11/GRxBiosims-2019-1-1024x683.png)
![GRx+Biosims 2019 GRx+Biosims 2019](https://biosimilarscouncil.org/wp-content/uploads/2019/11/GRxBiosims-2019-1024x683.png)
![announcement increasing patient access to biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2019/10/announcement-1024x683.jpg)
![Naming Biosimilars Naming Biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2019/10/Naming-Biosimilars-1024x683.png)
![Resource (Extra Large) (10)](https://biosimilarscouncil.org/wp-content/uploads/2019/10/Resource-Extra-Large-10.jpg)
When it comes to ensuring medicines — including biosimilars — are safe and effective for patients, the FDA remains the… Read more »
![barriers to biosimilar adoption barriers to biosimilar adoption](https://biosimilarscouncil.org/wp-content/uploads/2019/09/biosimilar_adoption-1024x683.jpg)
![report-card-thumb](https://biosimilarscouncil.org/wp-content/uploads/2019/07/report-card-thumb.jpg)
![benefit-healthcare](https://biosimilarscouncil.org/wp-content/uploads/2019/06/benefit-healthcare.png)
Dr. Sameer Awsare, Internal Medicine Physician and Associate Executive Director at Kaiser Permanente Medical Group, sat down with the Biosimilars… Read more »
![failure-to-launch](https://biosimilarscouncil.org/wp-content/uploads/2019/06/failure-to-launch.png)
![sameer image 2 are biosimilars safe](https://biosimilarscouncil.org/wp-content/uploads/2019/06/Resource-extra-large-2.png)
Dr. Sameer Awsare, Internal Medicine Physician and Associate Executive Director at Kaiser Permanente Medical Group, sat down with the Biosimilars… Read more »
![shutterstock_426481501](https://biosimilarscouncil.org/wp-content/uploads/2019/06/shutterstock_426481501.jpg)
![shutterstock_1349493995](https://biosimilarscouncil.org/wp-content/uploads/2019/06/shutterstock_1349493995-1024x684.jpg)
Dr. Sameer Awsare, Internal Medicine Physician and Associate Executive Director at Kaiser Permanente Medical Group, sat down with the Biosimilars… Read more »
![sameer image 3 what is a biosimilar](https://biosimilarscouncil.org/wp-content/uploads/2019/06/Resource-extra-large-3.png)
Dr. Sameer Awsare, Internal Medicine Physician and Associate Executive Director at Kaiser Permanente Medical Group, sat down with the Biosimilars… Read more »
![shutterstock_571849393](https://biosimilarscouncil.org/wp-content/uploads/2019/06/shutterstock_571849393.jpg)
![naming](https://biosimilarscouncil.org/wp-content/uploads/2019/06/naming.jpg)
![shutterstock_511615573 interchangeable insulin](https://biosimilarscouncil.org/wp-content/uploads/2019/05/shutterstock_511615573.jpg)
![shutterstock_606777308](https://biosimilarscouncil.org/wp-content/uploads/2019/05/shutterstock_606777308.jpg)
![Chip-Davis](https://biosimilarscouncil.org/wp-content/uploads/2019/05/Chip-Davis.jpg)
![nafta-web-header](https://biosimilarscouncil.org/wp-content/uploads/2019/05/nafta-web-header.jpg)
A recent series in Health Affairs questioned whether competition from biosimilar medicines is a viable path to providing relief from… Read more »
![interchangeability vs biosimilars interchangeability vs biosimilar](https://biosimilarscouncil.org/wp-content/uploads/2019/05/interchangeability-vs-biosimilars-1024x682.png)
![Supreme-Court](https://biosimilarscouncil.org/wp-content/uploads/2019/04/Supreme-Court-1-1024x683.png)
![Biosimilars-Video-Cover](https://biosimilarscouncil.org/wp-content/uploads/2019/02/Biosimilars-Video-Cover-1024x683.jpg)
![Biosimilars Council Recap of Access! 2019 Biosimilars Council Recap of Access! 2019](https://biosimilarscouncil.org/wp-content/uploads/2019/03/Biosimilars-Council-Recap-of-Access-2019-1024x682.jpg)
![Brand Efforts Seek to Limit Patient Access to Biosimilars Brand Efforts Seek to Limit Patient Access to Biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2019/03/Brand-Efforts-Seek-to-Limit-Patient-Access-to-Biosimilars.png)
![Infographic-Biosimilars-Reaches-Patients-Floating-banner_4-scaled_1](https://biosimilarscouncil.org/wp-content/uploads/2022/05/Infographic-Biosimilars-Reaches-Patients-Floating-banner_4-scaled_1-1024x568.jpg)
![Biosimilars Council - Biosimilars Approvals Speeding Up Biosimilars Council - Biosimilars Approvals Speeding Up](https://biosimilarscouncil.org/wp-content/uploads/2018/12/Biosimilars-Approvals-Speeding-Up-1024x683.jpg)
![Biosimilars Education Course for Clinicians Biosimilars Education Course for Clinicians](https://biosimilarscouncil.org/wp-content/uploads/2019/03/Biosimilars-Education-Course-for-Clinicians-1024x683.jpg)
![Photo of the steps and columns at the U.S. Supreme Court Stairs and columns in front of the United States Supreme Court in Washington DC.](https://biosimilarscouncil.org/wp-content/uploads/2019/03/Taking-Steps-to-Increase-Patient-Access-to-Life-Altering-Biosimilar-Medicines-1024x681.jpg)
![Biosimilars Council - Pass the CREATES Act Biosimilars Council - Pass the CREATES Act](https://biosimilarscouncil.org/wp-content/uploads/2019/03/Pass-the-CREATES-Act-1024x683.jpg)
![Frontiers for Public Health Study - Biologics Frontiers for Public Health Study - Biologics](https://biosimilarscouncil.org/wp-content/uploads/2019/03/Frontiers-for-Public-Health-Study-Biologics-1024x683.jpg)
![APhA - Biosimilars Council - Biosimilars Basics for Patients APhA - Biosimilars Council - Biosimilars Basics for Patients](https://biosimilarscouncil.org/wp-content/uploads/2019/03/APhA-Biosimilars-Council-Biosimilars-Basics-for-Patients-1024x682.jpg)
![Biosimilars Council - IQVIA Report - Advancing Biosimilar Sustainability in Europe Biosimilars Council - IQVIA Report - Advancing Biosimilar Sustainability in Europe](https://biosimilarscouncil.org/wp-content/uploads/2019/03/IQVIA-Report-Advancing-Biosimilar-Sustainability-in-Europe-1024x683.jpg)
![Drug Savings and Access](https://biosimilarscouncil.org/wp-content/uploads/2019/05/Drug-Savings-and-Access-1024x576.png)
![EMA-Building](https://biosimilarscouncil.org/wp-content/uploads/2018/09/EMA-Building.jpg)
![Biosimilars Council - Renegotiated NAFTA Event Biosimilars Council - Renegotiated NAFTA Event](https://biosimilarscouncil.org/wp-content/uploads/2018/09/Pills-and-Biosimilars-v2-1.jpg)
![Biosimilars Council - AAM This Month - August - Pills Background Biosimilars Council - AAM This Month - August - Pills Background](https://biosimilarscouncil.org/wp-content/uploads/2018/09/shutterstock_317904674.jpg)
![Biosimilars Council - Doctor Writing Prescription Biosimilars Council - Doctor Writing Prescription](https://biosimilarscouncil.org/wp-content/uploads/2018/09/shutterstock_134290640.jpg)
![Biosimilars Council - Doctors Standing Together Biosimilars Council - Doctors Standing Together](https://biosimilarscouncil.org/wp-content/uploads/2018/08/shutterstock_184351451.jpg)
![IGBA Position on Identification of Biological, including Biosimilar Medicines - Cover Image IGBA Position on Identification of Biological, including Biosimilar Medicines - Cover Image](https://biosimilarscouncil.org/wp-content/uploads/2018/08/shutterstock_259294352.jpg)
![The Biosimilars Council - Female Pharmacist with Customer The Biosimilars Council - Female Pharmacist with Customer](https://biosimilarscouncil.org/wp-content/uploads/2018/08/shutterstock_353390231-1024x683.png)
![The Biosimilars Council - Understanding Biologic and Biosimilar Drugs The Biosimilars Council - Understanding Biologic and Biosimilar Drugs](https://biosimilarscouncil.org/wp-content/uploads/2018/08/ACS-CAN-Cover-Photo-1024x683.jpg)
![The Biosimilars Council - U.S. Capitol Building at Sunset The Biosimilars Council - U.S. Capitol Building at Sunset](https://biosimilarscouncil.org/wp-content/uploads/2018/08/shutterstock_710537416.jpg)
![Biosimilars Council - Doctor Shaking Hand of Patient Biosimilars Council - Doctor Shaking Hand of Patient](https://biosimilarscouncil.org/wp-content/uploads/2018/08/shutterstock_1037540998.jpg)
![Capture22](https://biosimilarscouncil.org/wp-content/uploads/2018/08/Capture22.png)
![The Biosimilars Council - Seniors Sitting at a Meeting The Biosimilars Council - Seniors Sitting at a Meeting](https://biosimilarscouncil.org/wp-content/uploads/2018/08/shutterstock_1077274721.jpg)
![Biosimilars-Action-Plan---Video-Cover](https://biosimilarscouncil.org/wp-content/uploads/2018/07/Biosimilars-Action-Plan-Video-Cover.jpg)
![The Biosimilars Council - 2018 Access and Savings Report Cover Zoomed In The Biosimilars Council - 2018 Access and Savings Report Cover Zoomed In](https://biosimilarscouncil.org/wp-content/uploads/2018/07/Hero-Banner-1.jpg)
![myths vs facts infographic biosimilar myths vs facts](https://biosimilarscouncil.org/wp-content/uploads/2018/07/Resource-extra-large-8.png)
![The Biosimilars Council - Skyrocketing Drug Prices The Biosimilars Council - Skyrocketing Drug Prices](https://biosimilarscouncil.org/wp-content/uploads/2018/07/skyrocket-1024x683.jpg)
![The Biosimilars Council - Breaking Through on Biosimilars Whitepaper The Biosimilars Council - Breaking Through on Biosimilars Whitepaper](https://biosimilarscouncil.org/wp-content/uploads/2018/08/White-Paper-Photo-1024x683.jpg)
![About Biosimilars Council - T-cell background About the Biosimilars Council - T-cell background](https://biosimilarscouncil.org/wp-content/uploads/2018/04/iStock-538032878-e1521119921959-1024x926.jpg)
![Developing a Robust Biosimilars Market in the U.S. Developing a Robust Biosimilars Market in the U.S.](https://biosimilarscouncil.org/wp-content/uploads/2018/07/shutterstock_240295861-1024x683.png)
![Biosimilars Council - Large Meeting with Conference Attendees Biosimilars Council - Large Meeting with Conference Attendees](https://biosimilarscouncil.org/wp-content/uploads/2018/05/shutterstock_687716251.jpg)
![a safe and effective option - infographic biosimilars - a safe and effective option](https://biosimilarscouncil.org/wp-content/uploads/2018/04/Resource-extra-large-5.png)
![breaking down barriers infographic biosimilars - breaking down barriers infographic](https://biosimilarscouncil.org/wp-content/uploads/2019/10/Resource-extra-large-7.png)
![About Biosimilars Council - T-cell background About the Biosimilars Council - T-cell background](https://biosimilarscouncil.org/wp-content/uploads/2018/04/iStock-538032878-e1521119921959-1024x926.jpg)
![Paving the Way for Biosimilars Paving the Way for Biosimilars](https://biosimilarscouncil.org/wp-content/uploads/2018/04/shutterstock_526769428.jpg)
![Patient Access Report: Biosimilars in the United States Patient Access Report: Biosimilars in the United States](https://biosimilarscouncil.org/wp-content/uploads/2018/04/shutterstock_428285359.jpg)
![Biosimilars Council - Microscope Up Close Biosimilars Council - Microscope Up Close](https://biosimilarscouncil.org/wp-content/uploads/2018/04/shutterstock_107761853.jpg)
![Skyrocketing Drug Prices](https://biosimilarscouncil.org/wp-content/uploads/2019/05/Skyrocketing-Drug-Prices-1024x574.png)
![The Biosimilars Council - GRxBiosims Event Banner The Biosimilars Council - GRxBiosims Event Banner](https://biosimilarscouncil.org/wp-content/uploads/2018/07/TBC-Banner-GRxBiosims-event-1024x683.jpg)
![The Biosimilars Council - People Meeting Image The Biosimilars Council - People Meeting Image](https://biosimilarscouncil.org/wp-content/uploads/2018/07/iStock-491748486-1024x683.jpg)
![Biosimilars Council - Bottles being filled Biosimilars Council - Bottles being filled](https://biosimilarscouncil.org/wp-content/uploads/2018/03/shutterstock_271658528.jpg)
The Naming of Biosimilar Medicines Worldwide Should Promote Patient Safety and Prescriber Confidence
![shutterstock_1040956534](https://biosimilarscouncil.org/wp-content/uploads/2019/05/shutterstock_1040956534-1024x683.jpg)
![Biosimilars Council - Pharmacists looking at Computer Biosimilars Council - Pharmacists looking at Computer](https://biosimilarscouncil.org/wp-content/uploads/2018/03/shutterstock_1093335578.jpg)
![Biosimilars Council - FDA Website Screenshot Biosimilars Council - FDA Website Screenshot](https://biosimilarscouncil.org/wp-content/uploads/2018/02/shutterstock_1086968018-1024x683.jpg)
![Biosimilars Council - Doctor with Child Patient Biosimilars Council - Doctor with Child Patient](https://biosimilarscouncil.org/wp-content/uploads/2018/02/shutterstock_228381355.jpg)
![The Biosimilars Council - Doctor discussing with happy patient The Biosimilars Council - Doctor discussing with happy patient](https://biosimilarscouncil.org/wp-content/uploads/2017/12/shutterstock_740979067-e1626193196502.jpg)
![The Biosimilars Council - Doctor taking patient blood pressure The Biosimilars Council - Doctor taking patient blood pressure](https://biosimilarscouncil.org/wp-content/uploads/2017/12/pexels-photo-905874-1024x683.jpeg)
Biosimilars hold great promise for patients seeking access to more affordable versions of critical medicines, but also for a health care system facing unsustainable, increasing costs. One of the most immediate challenges to biosimilars uptake in the United State sis the lack of […]
![Medicare Part B Issue Brief Medicare Part B Issue Brief](https://biosimilarscouncil.org/wp-content/uploads/2018/07/shutterstock_506803990.jpg)
![Biosimilars Medicare Part D Biosimilars Medicare Part D](https://biosimilarscouncil.org/wp-content/uploads/2017/11/shutterstock_532679098.jpg)
![The Biosimilars Council - Doctors Discussing in a Circle The Biosimilars Council - Doctors Discussing in a Circle](https://biosimilarscouncil.org/wp-content/uploads/2017/10/shutterstock_400845949.jpg)
In the fast-paced world of health care, the role of the patient continues to evolve from passive to active. One of the most pressing issues patients face is the cost of their medications, which can serve as a significant barrier to access, especially for expensive brand-name biologic medicines[…]
![The Biosimilars Council - Doctors Applauding The Biosimilars Council - Doctors Applauding](https://biosimilarscouncil.org/wp-content/uploads/2017/09/shutterstock_138796235.jpg)
![The Biosimilars Council - Doctor with Stethoscope and pens The Biosimilars Council - Doctor with Stethoscope and pens](https://biosimilarscouncil.org/wp-content/uploads/2017/07/doctor-medical-medicine-health-42273-1024x683.jpeg)
![Report-Cover-2017-AAM2](https://biosimilarscouncil.org/wp-content/uploads/2017/07/Report-Cover-2017-AAM2-1024x683.png)
![BioC](https://biosimilarscouncil.org/wp-content/uploads/2017/06/BioC-1024x683.jpg)
On June 7th, The Atlantic presented “The Next Drugs: The Future for Biosimilars – An Atlantic Policy Update on Biosimilars” at the Newseum in Washington, D.C. The third in a series of Atlantic biosimilars briefings underwritten by The Biosimilars Council […]
![BillCassidy&JoieChen (1)](https://biosimilarscouncil.org/wp-content/uploads/2017/06/BillCassidyJoieChen-1-1024x683.jpg)
Biosimilars not only have the unique ability to provide patients with much-needed access to lower-cost complex therapies, but also offer the potential for billions in patient, insurer and health system savings. But there are barriers […]
![Pen and Notepad](https://biosimilarscouncil.org/wp-content/uploads/2017/05/shutterstock_86288800.jpg)
![The Biosimilars Council - Table with Phones from Overhead The Biosimilars Council - Table with Phones from Overhead](https://biosimilarscouncil.org/wp-content/uploads/2017/05/pexels-photo-926987-1024x683.jpeg)
Working in coordination with The Atlantic, an award-winning publication that covers politics, business, and technology, The Biosimilars Council will continue its efforts to educate consumers about biosimilars by bringing together key stakeholders to debate the state and future of biosimilars […]
![Doctor with Child Patient Doctor forward with child patient behind](https://biosimilarscouncil.org/wp-content/uploads/2017/05/doctor-patient-child2-1-1024x683.jpg)
The country has undergone a great deal of change from December to today – but one thing that has not changed is that Americans want action to bring down the price of prescription drugs. A recent Kaiser Health Tracking Poll showed that over 60% of Americans believe lowering the cost of […]
![FDA APPROVED](https://biosimilarscouncil.org/wp-content/uploads/2017/03/chip-davis-atlanticlive-future-biosimilars-1024x683-1024x683.jpg)
On March 15th, The Atlantic presented “The Next Drugs: The Future for Biosimilars – An Atlantic Policy Briefing” at the Newseum in Washington, D.C. Underwritten by The Biosimilars Council, more than 100 influencers from across the […]
![2016-Atlantic-Next-Drugs-240](https://biosimilarscouncil.org/wp-content/uploads/2017/03/2016-Atlantic-Next-Drugs-240-1024x683.jpg)
Underwritten by The Biosimilars Council The Atlantic gathered key stakeholders to examine the emerging world of biosimilars and their regulatory framework in the United States. How does the Food and Drug Administration implement[…]
![Untitled-2](https://biosimilarscouncil.org/wp-content/uploads/2017/03/Untitled-2-1024x683.png)
Stay Informed About The Latest Issues.
Subscribe to the monthly Biosimilars Bulletin.